| Literature DB >> 21261566 |
Dirk Haufe1, Klaus G Dahmen, Oliver Tiebel, Matthias Hübler, Thea Koch.
Abstract
The intraperitoneal instillation of perfluorocarbons augmented systemic oxygenation and was protective in mesenteric ischemia-reperfusion and experimental lung injury. To study biocompatibility and potential anti-inflammatory effects of intraperitoneal perfluorocarbons, we evaluated the influence of perfluorohexane and/or inflammatory stimuli on human mesothelial cells in vitro. Perfluorohexane exposure neither impaired cell viability nor induced cellular activation. TNFα enhanced ICAM-1 expression, which was not attenuated by simultaneous perfluorohexane treatment. Concentration of intracellular surfactant protein A tended to be higher in perfluorohexane treated cells compared to controls. Our in vitro data add further evidence that intraperitoneal perfluorocarbon application is feasible without adverse local effects.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21261566 DOI: 10.3109/10731199.2010.550264
Source DB: PubMed Journal: Artif Cells Blood Substit Immobil Biotechnol ISSN: 1073-1199